Utimco has appointed Thomas Harris as its new chief executive and chief investment officer effective August 1.

Osage University Partners has launched efforts to raise a $250m third fund.

Existing investor FoxKiser has returned for a $32.5m round that follows the cancer immunotherapy T cell developer's series A two years ago.

Cambridge Material Testing Solutions has been established to develop software and equipment that let industrial clients assess the condition of their metal assets.

UCL and Syncona have both returned for Freeline's series B round, which will spur clinical development of the spinout's gene therapy for haemophilia B.

Elph, co-founded by UC Berkeley graduates, has raised $875,000 in a round backed by the House Fund.

North Carolina State University semiconductor material spinout HexaTech will seek $3.5m from its latest round to bring its overall funding to roughly $12m.